Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine

被引：21

作者：

Beaumont, Elodie

Roingeard, Philippe ^{[1
]}

机构：

[1] Univ Tours, INSERM, U966, Tours, France

来源：

VACCINE | 2015年 / 33卷 / 08期

关键词：

Viral hepatitis; Preventive vaccination; Subviral envelope particles; Immune response; Liver diseases; IMMUNOGENICITY;

D O I：

10.1016/j.vaccine.2015.01.007

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The development of an effective, affordable prophylactic vaccine against hepatitis C virus (HCV) remains a medical priority. The recently described chimeric HBV-HCV subviral envelope particles could potentially be used for this purpose, as they could be produced by industrial procedures adapted from those established for the hepatitis B virus (HBV) vaccine. We show here, in an animal model, that pre-existing immunity acquired through HBV vaccination does not influence the immunogenicity of the HCV E2 protein presented by these chimeric particles. Thus, these chimeric HBV HCV subviral envelope particles could potentially be used as a booster in individuals previously vaccinated against HBV, to induce protective immunity to HCV. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：973 / 976

页数：4

共 15 条

[1] Prospects for prophylactic hepatitis C vaccines based on virus-like particles
Beaumont, Elodie
Roingeard, Philippe
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (05) : 1112 - 1118
[2] Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine
Beaumont, Elodie
Patient, Romuald
Hourioux, Christophe
Dimier-Poisson, Isabelle
Roingeard, Philippe
[J]. HEPATOLOGY, 2013, 57 (04) : 1303 - 1313
[3] Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination
Chan, Paul K. S.
Ngai, Karry L. K.
Lao, Terence T.
Wong, Martin C. S.
Cheung, Theresa
Yeung, Apple C. M.
Chan, Martin C. W.
Luk, Scotty W. C.
[J]. PLOS ONE, 2014, 9 (09):
[4] Effects of Pre-Existing Anti-Carrier Immunity and Antigenic Element Multiplicity on Efficacy of a Modular Virus-Like Particle Vaccine
Chuan, Yap P.
Rivera-Hernandez, Tania
Wibowo, Nani
Connors, Natalie K.
Wu, Yang
Hughes, Fiona K.
Lua, Linda H. L.
Middelberg, Anton P. J.
[J]. BIOTECHNOLOGY AND BIOENGINEERING, 2013, 110 (09) : 2343 - 2351
[5] Treatment as prevention and cure towards global eradication of hepatitis C virus
Hagan, Liesl M.
Wolpe, Paul Root
Schinazi, Raymond F.
[J]. TRENDS IN MICROBIOLOGY, 2013, 21 (12) : 625 - 633
[6] Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Hanafiah, Khayriyyah Mohd
Groeger, Justina
Flaxman, Abraham D.
Wiersma, Steven T.
[J]. HEPATOLOGY, 2013, 57 (04) : 1333 - 1342
[7] A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
Lell, Bertrand
Agnandji, Selidji
von Glasenapp, Isabelle
Haertle, Sonja
Oyakhiromen, Sunny
Issifou, Saadou
Vekemans, Johan
Leach, Amanda
Lievens, Marc
Dubois, Marie-Claude
Demoitie, Marie-Ange
Carter, Terrell
Villafana, Tonya
Ballou, W. Ripley
Cohen, Joe
Kremsner, Peter G.
[J]. PLOS ONE, 2009, 4 (10):
[8] Bioengineering Virus-Like Particles as Vaccines
Lua, Linda H. L.
Connors, Natalie K.
Sainsbury, Frank
Chuan, Yap P.
Wibowo, Nani
Middelberg, Anton P. J.
[J]. BIOTECHNOLOGY AND BIOENGINEERING, 2014, 111 (03) : 425 - 440
[9] Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine
Netter, HJ
Woo, WP
Tindle, R
Macfarlan, RI
Gowans, EJ
[J]. VACCINE, 2003, 21 (21-22) : 2692 - 2697
[10] Publication WHO, 2010, VACCINE, V28, P589

← 1 2 →